Biological Products, Except Diagnostic Substances (Biotech) - Insider Trading Data

Insiders are officers, directors, or significant investors. This page shows insider sentiment and transactions for the Biological industry. Research shows that insider trades are predictive of future stock returns. By examining insider trades for an industry, we can understand what well-informed people think of the overall future industry prospects.

Biological Products, Except Diagnostic Substances (Biotech) - Insider Buy/Sell Ratio

Insider selling and buying is a useful indicator for analyzing the market because it serves as a proxy for their optimism or pessimism in their own companies. By looking at ratio of total selling and buying across the entire market, we might be able to draw some conclusions about the future market.

We offer two charts here. The first one shows the total dollar volume of buying and selling by insiders. The second chart shows the ratio of the number of insiders selling, vs. the number of insiders buying. In both charts, we filter out trades made by indirect holders (such as trusts), and 10% owners (who, although considered an 'insider' by the SEC, do not actually manage the companies in which they are considered insiders).

Corporate Insider Buy Sell Ratio (Dollar Volume) - Biological Products, Except Diagnostic Substances (Biotech)
Corporate Insider Buy Sell Ratio (Insider Count) - Biological Products, Except Diagnostic Substances (Biotech)
Biological Products, Except Diagnostic Substances (Biotech) - Transaction History

Click the link icon to see the full transaction history. Transactions reported as part of a 10b5-1 automatic trading plan will have an X in the column marked 10b-5.

Tran
Date
Security Form Insider Code 10b5-1 Direct Share
Price
Shares
Changed
2026-04-13 VOR / Vor Biopharma Inc. 4 RA CAPITAL MANAGEMENT, LLC See footnotes S - Sale I 16.15 -530,610
2026-04-13 ADPT / Adaptive Biotechnologies Corporation 4 RUBINSTEIN JULIE S - Sale D 14.08 -3,338
2026-04-13 ADPT / Adaptive Biotechnologies Corporation 4 RUBINSTEIN JULIE S - Sale D 12.95 -15,722
2026-04-13 ADPT / Adaptive Biotechnologies Corporation 4 RUBINSTEIN JULIE M - Exercise D 7.27 8,109
2026-04-13 ADPT / Adaptive Biotechnologies Corporation 4 RUBINSTEIN JULIE M - Exercise D 8.46 6,613
2026-04-10 CGEN / Compugen Ltd. 4/A Levine Zurit S - Sale D 2.564 -3,125
2026-04-10 ADPT / Adaptive Biotechnologies Corporation 4 RUBINSTEIN JULIE S - Sale D 12.75 -18,660
2026-04-10 CGEN / Compugen Ltd. 4 Levine Zurit S - Sale D 2.564 -3,125
2026-04-10 ADPT / Adaptive Biotechnologies Corporation 4 RUBINSTEIN JULIE S - Sale D 13.48 -400
2026-04-10 TSHA / Taysha Gene Therapies, Inc. 4 Nagendran Sukumar S - Sale D 4.46 -200,000
2026-04-10 VOR / Vor Biopharma Inc. 4 RA CAPITAL MANAGEMENT, LLC See footnotes S - Sale I 15.75 -828
2026-04-10 KYMR / Kymera Therapeutics, Inc. 4 Goodman Noah S - Sale D 87.35 -2,000
2026-04-10 MESO / Mesoblast Limited - Depositary Receipt (Common Stock) 4 George Gregory Held by Grant George, who has granted power of attorney to Dr. George. P - Purchase I 1.48 2,324,072
2026-04-10 MESO / Mesoblast Limited - Depositary Receipt (Common Stock) 4 George Gregory Held by Grant George, who has granted power of attorney to Dr. George. P - Purchase I 1.48 2,324,072
2026-04-10 TSHA / Taysha Gene Therapies, Inc. 4 Nagendran Sukumar M - Exercise D 1.71 19,021
2026-04-10 CGEN / Compugen Ltd. 4/A Levine Zurit M - Exercise D 1.15 2,000
2026-04-10 CGEN / Compugen Ltd. 4 Levine Zurit M - Exercise D 0.8292 1,125
2026-04-10 ADPT / Adaptive Biotechnologies Corporation 4 RUBINSTEIN JULIE M - Exercise D 7.27 14,722
2026-04-10 CGEN / Compugen Ltd. 4/A Levine Zurit M - Exercise D 0.8292 1,125
2026-04-10 CGEN / Compugen Ltd. 4 Levine Zurit M - Exercise D 1.15 2,000
2026-04-09 ADPT / Adaptive Biotechnologies Corporation 4 RUBINSTEIN JULIE S - Sale D 13.79 -16,960
2026-04-09 GLUE / Monte Rosa Therapeutics, Inc. 4 Nickson Philip S - Sale D 17.6925 -5,845
2026-04-09 ADPT / Adaptive Biotechnologies Corporation 4 RUBINSTEIN JULIE S - Sale D 14.44 -2,100
2026-04-09 KYMR / Kymera Therapeutics, Inc. 4 Goodman Noah S - Sale D 86.6180 -3,094
2026-04-09 RLAY / Relay Therapeutics, Inc. 4 Catinazzo Thomas S - Sale D 15.00 -1,800
2026-04-09 TWST / Twist Bioscience Corporation 4 Laponis Adam S - Sale D 49.889 -2,597
2026-04-09 KYMR / Kymera Therapeutics, Inc. 4 Goodman Noah S - Sale D 89 -2,500
2026-04-09 KYMR / Kymera Therapeutics, Inc. 4 Goodman Noah S - Sale D 87.1109 -2,670
2026-04-09 VOR / Vor Biopharma Inc. 4 RA CAPITAL MANAGEMENT, LLC See footnotes S - Sale I 16.59 -135,201
2026-04-09 MESO / Mesoblast Limited - Depositary Receipt (Common Stock) 4 George Gregory As above. P - Purchase I 1.43 10,000
2026-04-09 MESO / Mesoblast Limited - Depositary Receipt (Common Stock) 4 George Gregory As above. P - Purchase I 14.30 10,000
2026-04-09 MESO / Mesoblast Limited - Depositary Receipt (Common Stock) 4 George Gregory As above. P - Purchase I 14.10 10,000
2026-04-09 MESO / Mesoblast Limited - Depositary Receipt (Common Stock) 4 George Gregory As above. P - Purchase I 1.41 10,000
2026-04-09 MESO / Mesoblast Limited - Depositary Receipt (Common Stock) 4 George Gregory As above. P - Purchase I 14.30 10,000
2026-04-09 MESO / Mesoblast Limited - Depositary Receipt (Common Stock) 4 George Gregory As above. P - Purchase I 1.43 10,000
2026-04-09 MESO / Mesoblast Limited - Depositary Receipt (Common Stock) 4 George Gregory As above. P - Purchase I 14.25 10,000
2026-04-09 MESO / Mesoblast Limited - Depositary Receipt (Common Stock) 4 George Gregory As above. P - Purchase I 14.30 20,000
2026-04-09 MESO / Mesoblast Limited - Depositary Receipt (Common Stock) 4 George Gregory As above. P - Purchase I 1.44 4,760
2026-04-09 MESO / Mesoblast Limited - Depositary Receipt (Common Stock) 4 George Gregory As above. P - Purchase I 14.39 500,000
2026-04-09 MESO / Mesoblast Limited - Depositary Receipt (Common Stock) 4 George Gregory As above. P - Purchase I 1.46 105,000
2026-04-09 MESO / Mesoblast Limited - Depositary Receipt (Common Stock) 4 George Gregory As above. P - Purchase I 14.40 10,000
2026-04-09 MESO / Mesoblast Limited - Depositary Receipt (Common Stock) 4 George Gregory As above. P - Purchase I 14.40 4,760
2026-04-09 MESO / Mesoblast Limited - Depositary Receipt (Common Stock) 4 George Gregory As above. P - Purchase I 14.25 5,240
2026-04-09 MESO / Mesoblast Limited - Depositary Receipt (Common Stock) 4 George Gregory As above. P - Purchase I 1.44 10,000
2026-04-09 MESO / Mesoblast Limited - Depositary Receipt (Common Stock) 4 George Gregory As above. P - Purchase I 1.43 886,890
2026-04-09 MESO / Mesoblast Limited - Depositary Receipt (Common Stock) 4 George Gregory As above. P - Purchase I 1.44 500,000
2026-04-09 MESO / Mesoblast Limited - Depositary Receipt (Common Stock) 4 George Gregory As above. P - Purchase I 1.43 5,240
2026-04-09 MESO / Mesoblast Limited - Depositary Receipt (Common Stock) 4 George Gregory As above. P - Purchase I 1.43 10,000
2026-04-09 MESO / Mesoblast Limited - Depositary Receipt (Common Stock) 4 George Gregory As above. P - Purchase I 14.30 5,000
2026-04-09 MESO / Mesoblast Limited - Depositary Receipt (Common Stock) 4 George Gregory As above. P - Purchase I 1.43 5,000
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)